Risk and Benefit for Targeted Therapy Agents in Pediatric Phase II Trials in Oncology: A Systematic Review with a Meta-Analysis.

导出 OA

翻译打印收藏纠错

作者： Karolina,Strzebonska ^[1] ; Mateusz T,Wasylewski ^[1] ; Lucja,Zaborowska ^[1] ; Maciej,Polak ^[1] ; Emilia,Slugocka ^[2] ; Jakub,Stras ^[1] ; Mateusz,Blukacz ^[1] ; Bishal,Gyawali ^[3] ; Marcin,Waligora ^[4]

作者单位： Research Ethics in Medicine Study Group (REMEDY), Department of Philosophy and Bioethics, Jagiellonian University Medical College, ul. Kopernika 40, 31-501, Kraków, Poland. ^[1] Chair of Epidemiology and Population Studies, Jagiellonian University Medical College, Kraków, Poland. ^[2] Institute of Psychology, University of Silesia, Katowice, Poland. ^[3] Department of Oncology and the Department of Public Health Sciences, Queen's University, Kingston, ON, Canada. ^[4] Research Ethics in Medicine Study Group (REMEDY), Department of Philosophy and Bioethics, Jagiellonian University Medical College, ul. Kopernika 40, 31-501, Kraków, Poland. m.waligora@uj.edu.pl. ^[5]

主题词抗肿瘤药(Antineoplastic Agents);医学肿瘤学(Medical Oncology);肿瘤(Neoplasms)

DOI 10.1007/s11523-021-00822-5

PMID 34110559

发布时间 2023-11-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交